Latest Executive Incentives News

Breville Group Limited reported robust FY25 results with 10.9% revenue growth and a 10.2% rise in EBIT, underpinned by strong coffee segment performance and strategic geographic expansion. The company also advanced its sustainability agenda, achieving net zero Scope 1 and 2 emissions.

Cleanaway Waste Management posted a 14.6% rise in underlying EBIT to $411.8 million for FY25, driven by solid waste services growth and strategic acquisitions. However, the Board exercised discretion to reduce executive short-term incentives by 30% due to safety performance issues including three fatalities.

BHP Group Limited reported strong FY2025 financial results driven by record copper production and operational excellence, while advancing key growth projects and sustainability goals. The company maintained its dividend payout and navigated cost escalations at the Jansen potash project alongside ongoing Samarco dam failure remediation.

Region RE Limited reported a modest increase in funds from operations per security to 15.5 cents for FY25, supported by a resilient retail portfolio and strong capital management. The company maintains a positive outlook for FY26 with continued focus on portfolio curation and sustainability initiatives.

Australian Strategic Materials has announced the vesting of over 400,000 performance rights granted to its Managing Director and senior executives, marking a key moment in executive remuneration and potential share dilution.

Audinate Group Limited reported a 32% revenue decline and a net loss in FY25 amid industry headwinds, while expanding gross margins and completing a strategic acquisition to boost its video capabilities.

Bravura Solutions Limited reported a robust FY25 with revenue growth of 3.1% and a 177% increase in underlying net profit, driven by operational efficiencies and a one-off software licence sale. The company announced a special dividend and continues its leadership transition with an interim CEO in place.

Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.

Vitrafy Life Sciences reported strong FY25 progress with 75% sales growth, advanced cryopreservation technology development, and a robust cash position. The company outlines a clear commercialisation roadmap for FY26, including product launches and expanded U.S. operations.

Mount Burgess Mining NL has secured agreements to extinguish nearly $4.7 million in legacy debt, converting a small portion into equity and options, positioning the company for renewed growth.

AVJennings shareholders have overwhelmingly approved a scheme of arrangement for a $0.655 per share cash acquisition by Proprium Capital Partners and AVID Property Group, marking a significant premium and a pivotal moment for the residential property developer.

ALS Limited reported a robust FY25 with 16% revenue growth to AUD 3 billion, underpinned by strong organic expansion and key acquisitions. Despite slight NPAT decline, the company advances its sustainability agenda and invests in global lab upgrades.